Assignee
VIRACTA SUBSIDIARY INC
US·4 granted patents·8 pending applications·2 citations·filing 2020–2025
Top patents by PatentIndex Score
12 records- 0188US2024390375A1Methods and compositions for treating viral or virally-induced conditionsVIRACTA SUBSIDIARY INC·Filed 2024·Application pending·0 cites
- 0287US11780822B2HDAC inhibitor solid state formsVIRACTA SUBSIDIARY INC·Filed 2022·Granted Oct 10, 2023·1 cites·20 claims
- 0383US11760748B2HDAC inhibitor solid state formsVIRACTA SUBSIDIARY INC·Filed 2022·Granted Sep 19, 2023·1 cites·20 claims
- 0480US12083119B2Methods and compositions for treating viral or virally-induced conditionsVIRACTA SUBSIDIARY INC·Filed 2021·Granted Sep 10, 2024·0 cites·4 claims
- 0573US2024101530A1Hdac inhibitor solid state formsVIRACTA SUBSIDIARY INC·Filed 2023·Application pending·0 cites
- 0670US12012396B2HDAC inhibitor solid state formsVIRACTA SUBSIDIARY INC·Filed 2023·Granted Jun 18, 2024·0 cites·18 claims
- 0767US2023023953A1Hdac inhibitor solid state formsVIRACTA SUBSIDIARY INC·Filed 2022·Application pending·0 cites
- 0866US2026000672A1Histone deacetylase inhibitors for use in immunotherapyVIRACTA SUBSIDIARY INC·Filed 2025·Application pending·0 cites
- 0959US2023149413A1Histone deacetylase inhibitors for use in immunotherapyVIRACTA SUBSIDIARY INC·Filed 2022·Application pending·0 cites
- 1057US2023382888A1Hdac inhibitor solid state formsVIRACTA SUBSIDIARY INC·Filed 2021·Application pending·0 cites
- 1156US2024366597A1Cancer treatment combinationsVIRACTA SUBSIDIARY INC·Filed 2022·Application pending·0 cites
- 1252US2022226322A1Methods of treating virally associated cancers with histone deacetylase inhibitorsVIRACTA SUBSIDIARY INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VIRACTA SUBSIDIARY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →